{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T01:15:05Z","timestamp":1794186905762,"version":"4.8.0"},"reference-count":30,"publisher":"University of Toronto Press Inc. (UTPress)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Liver Journal"],"published-print":{"date-parts":[[2026,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Ketamine-related cholangiopathy is increasingly being described in America, Europe, and Asia, paralleling increases in ketamine use globally. However, ketamine-related cholangiopathy has not been described in Canada previously. We report three cases of ketamine-related cholangiopathy in Calgary, Alberta.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Between May 2024 and April 2025, three patients were assessed by the University of Calgary Liver Unit in Calgary, Alberta, Canada. Case 1 was a 28-year-old female referred for elevated liver enzymes and features concerning for sclerosing cholangitis identified on magnetic resonance cholangiopancreatography. Case 2 was a 40-year-old male referred due to features of sclerosing cholangitis identified on magnetic resonance cholangiopancreatography. Case 3 was a 33-year-old female referred for elevated liver enzymes with biliary dilation on abdominal CT scan. In all cases, a history of chronic ketamine use and a negative comprehensive workup for other etiologies strongly suggested ketamine as the cause of their presentations. Case 1 had normalization of liver enzymes and marked improvement of radiographic biliary changes at 3-month follow-up after complete cessation of ketamine. Case 2 reduced ketamine use by 50% and experienced similar clinical improvement at 3-month follow-up. Case 3 continued using ketamine, resulting in worsening liver enzyme elevations and persistent biliary tree imaging abnormalities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Chronic ketamine use should be considered in patients presenting with liver enzyme elevation and\/or imaging evidence of biliary dilation. Increased awareness in Canada is essential to ensuring health care providers consider ketamine-related cholangiopathy in patients presenting with these clinical findings, as with ketamine cessation liver injury and biliary abnormalities are potentially reversible.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3138\/canlivj-2025-0033","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:58:06Z","timestamp":1772207886000},"page":"55-63","source":"Crossref","is-referenced-by-count":2,"title":["Chronic ketamine use resulting in a reversible cholangiopathy: A case series from a single Canadian centre and review of the literature"],"prefix":"10.3138","volume":"9","author":[{"given":"Bryce","family":"Tkachuk","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Swain","sequence":"additional","affiliation":[{"name":"Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly W","family":"Burak","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada"},{"name":"Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Calgary Liver Unit, University of Calgary, Calgary, Alberta, Canada"},{"name":"Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark G","family":"Swain","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of Calgary, Calgary, Alberta, Canada"},{"name":"Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Calgary Liver Unit, University of Calgary, Calgary, Alberta, Canada"},{"name":"Snyder Institute for Chronic Diseases, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1696","reference":[{"issue":"6","key":"r1","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1097\/ALN.0000000000003577","volume":"133","author":"Kamp J","year":"2020","journal-title":"Anesthesiology"},{"key":"r2","doi-asserted-by":"crossref","first-page":"1283733","DOI":"10.3389\/fpsyt.2023.1283733","volume":"14","author":"Chrenek C","year":"2024","journal-title":"Front Psychiatry"},{"key":"r3","unstructured":"Government of Canada. Ketamine. 2023. https:\/\/www.canada.ca\/en\/health-canada\/services\/substance-use\/controlled-illegal-drugs\/ketamine.html (Accessed December 8, 2025)."},{"issue":"11","key":"r4","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.2105\/AJPH.2021.306486","volume":"111","author":"Palamar JJ","year":"2021","journal-title":"Am J Public Health"},{"key":"r5","doi-asserted-by":"crossref","first-page":"101940","DOI":"10.1016\/j.toxrep.2025.101940","volume":"14","author":"Marongiu S","year":"2025","journal-title":"Toxicol Rep"},{"key":"r6","volume-title":"Canadian substance use survey\u2013summary of results 2023","author":"Health Canada","year":"2024"},{"key":"r7","volume-title":"Drug use among Ontario students, 1977\u20132009","author":"Paglia-Boak A","year":"2009"},{"issue":"9","key":"r8","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1081\/JA-200066866","volume":"40","author":"Barrett SP","year":"2005","journal-title":"Subst Use Misuse"},{"issue":"2","key":"r9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/bju.16404","volume":"134","author":"Belal M","year":"2024","journal-title":"BJU Int"},{"issue":"2","key":"r10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/hep.26459","volume":"58","author":"Turkish A","year":"2013","journal-title":"Hepatology"},{"issue":"10","key":"r11","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.cgh.2014.01.041","volume":"12","author":"Wong GL","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"r12","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00261-014-0173-2","volume":"39","author":"Yu WL","year":"2014","journal-title":"Abdom Imaging"},{"issue":"1","key":"r13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jhep.2018.03.006","volume":"69","author":"Seto WK","year":"2018","journal-title":"J Hepatol"},{"issue":"1","key":"r14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/hep.31650","volume":"74","author":"Knooihuizen SAI","year":"2021","journal-title":"Hepatology"},{"issue":"12","key":"r15","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s40264-021-01120-9","volume":"44","author":"Cotter S","year":"2021","journal-title":"Drug Saf"},{"issue":"1","key":"r16","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13054-022-04019-8","volume":"26","author":"Wendel-Garcia PD","year":"2022","journal-title":"Crit Care"},{"issue":"1","key":"r17","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12871-023-02006-2","volume":"23","author":"Henrie J","year":"2023","journal-title":"BMC Anesthesiol"},{"issue":"1","key":"r18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13256-024-04421-6","volume":"18","author":"Teymouri A","year":"2024","journal-title":"J Med Case Rep"},{"issue":"1","key":"r19","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/his.15435","volume":"87","author":"Chun J","year":"2025","journal-title":"Histopathology"},{"issue":"3","key":"r20","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/jamapsychiatry.2023.4945","volume":"81","author":"Wilkinson ST","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"r21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2982.2004.00525.x","volume":"16","author":"Liu CY","year":"2004","journal-title":"Neurogastroenterol Motil"},{"issue":"10","key":"r22","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s00134-021-06482-3","volume":"47","author":"de Tymowski C","year":"2021","journal-title":"Intensive Care Med"},{"issue":"12","key":"r23","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1007\/s00134-023-07257-8","volume":"49","author":"Leonhardt S","year":"2023","journal-title":"Intensive Care Med"},{"issue":"6","key":"r24","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/15563650.2023.2212125","volume":"61","author":"Schep LJ","year":"2023","journal-title":"Clin Toxicol (Phila)"},{"issue":"3","key":"r25","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.jhep.2022.05.011","volume":"77","author":"European Association for the Study of the Liver","year":"2022","journal-title":"J Hepatol"},{"issue":"2","key":"r26","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/hep.32771","volume":"77","author":"Bowlus CL","year":"2023","journal-title":"Hepatology"},{"key":"r27","volume-title":"Summary safety review\u2014ketamine\u2014assessing the potential risk of liver and bile duct damage","author":"Canada Go","year":"2020"},{"issue":"3","key":"r28","first-page":"e52","volume":"52","author":"Lo R","year":"2011","journal-title":"Singapore Med J"},{"issue":"10","key":"r29","doi-asserted-by":"crossref","first-page":"e1900","DOI":"10.14309\/01.ajg.0000868316.89866.2d","volume":"117","author":"Cheng K","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"r30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18332\/pht\/192742","volume":"4","author":"Grabie Y","year":"2024","journal-title":"Pub Health Toxicol"}],"container-title":["Canadian Liver Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/utppublishing.com\/doi\/pdf\/10.3138\/canlivj-2025-0033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T15:58:22Z","timestamp":1772639902000},"score":1,"resource":{"primary":{"URL":"https:\/\/utppublishing.com\/doi\/10.3138\/canlivj-2025-0033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2,1]]}},"alternative-id":["10.3138\/canlivj-2025-0033"],"URL":"https:\/\/doi.org\/10.3138\/canlivj-2025-0033","relation":{},"ISSN":["2561-4444"],"issn-type":[{"value":"2561-4444","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,1]]}}}